Topiramate for refractory schizophrenia [6]

American Journal of Psychiatry

Volumn 159, Issue 4, 2002, Pages 675-

  Millson, Richard C ^a   Owen, James A ^a   Lorberg, Gunter W ^a   Tackaberry, Liane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE;

ADULT; AGRANULOCYTOSIS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT FAILURE;

EID: 0036212573     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.4.675     Document Type: Letter

References (8)

1. Clozapine plus lamotrigine in treatment-resistant schizophrenia
2. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
3. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
4. An audit of topiramate use in a general neurology clinic
5. Dysfunctions in multiple interrelated systems as the neurological bases of schizophrenic symptom clusters
6. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia
7. Clozapine weight gain, plus topiramate weight loss
8. Topiramate for clozapine-induced seizures